ACE2 and SARS-CoV-2: Tissue or Plasma, Good or Bad?

Wenzel, Ulrich O; Kintscher, Ulrich

Wenzel, Ulrich O; Kintscher, Ulrich.

Wenzel UO; Department of Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Kintscher U; Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pharmacology, Center for Cardiovascular Research, Berlin, Germany.

Am J Hypertens ; 34(3): 274-277, 2021 04 02.

Article in English | MEDLINE | ID: covidwho-1387705

Subject(s)

Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors/pharmacology; COVID-19; Cardiovascular Diseases; Renin-Angiotensin System; SARS-CoV-2/physiology; Angiotensin-Converting Enzyme 2/blood; Angiotensin-Converting Enzyme 2/metabolism; COVID-19/blood; COVID-19/metabolism; COVID-19/virology; Cardiovascular Diseases/drug therapy; Cardiovascular Diseases/metabolism; Humans; Receptors, Virus/metabolism; Renin-Angiotensin System/drug effects; Renin-Angiotensin System/physiology; Virus Internalization/drug effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Renin-Angiotensin System / Angiotensin-Converting Enzyme Inhibitors / Cardiovascular Diseases / Angiotensin-Converting Enzyme 2 / SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Am J Hypertens Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: AJH

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google